道瓊斯指數
50,198.17
漲跌
-561.25-1.11%
在 MEXC 探索美國生物科技板塊股票,涵蓋專注於藥物研發、基因治療及生物學研究的公司。比較股價、當日漲跌、市值和成交量,全面瞭解生物科技行業動態。

今日美股市場走勢分化,道瓊斯指數漲跌幅為 -1.11%,標普 500 指數為 -0.23%,納斯達克綜合指數為 +0.42%。個股方面,2,092 隻上漲、3,021 隻下跌,市場整體呈現分化格局。
| # | 股票 | 52 週價格區間 | |||||
|---|---|---|---|---|---|---|---|
| 1 | 安進AMGN | $443.83 | -3.08% | 2.07M | $240.07B | $312.38 - $483.99 | 0.02% |
| 2 | 吉利德科學GILD | $168.98 | -0.75% | 3.54M | $209.59B | $116.88 - $176.58 | 0.02% |
| 3 | ModernaMRNA | $196.74 | -5.21% | 6.02M | $79.61B | $22.28 - $280.80 | 0.00% |
| 4 | IQVIA HoldingsIQV | $257.84 | +0.09% | 1.10M | $42.49B | $154.50 - $284.50 | 0.00% |
| 5 | BiogenBIIB | $251.37 | +0.25% | 903.77K | $37.16B | $160.36 - $261.00 | 0.00% |
| 6 | Revolution MedRVMD | $159.76 | -1.75% | 1.79M | $34.56B | $67.86 - $224.31 | 0.00% |
| 7 | 英賽德INCY | $117.84 | -1.08% | 777.07K | $24.02B | $89.25 - $132.60 | 0.00% |
| 8 | Medpace HoldingsMEDP | $646.94 | -0.95% | 167.84K | $18.10B | $373.00 - $693.97 | 0.00% |
| 9 | ExelixisEXEL | $68.27 | -0.34% | 1.47M | $16.66B | $39.71 - $73.69 | 0.00% |
| 10 | NeurocrineNBIX | $162.74 | -1.87% | 1.13M | $16.47B | $122.14 - $186.12 | 0.00% |
| 11 | Charles River Laboratories IntlCRL | $333.30 | +0.33% | 418.56K | $15.97B | $146.19 - $379.63 | 0.00% |
| 12 | Bio-TechneTECH | $72.75 | +0.15% | 2.36M | $11.43B | $43.20 - $72.88 | 0.00% |
| 13 | Repligen CorpRGEN | $172.63 | +6.46% | 1.12M | $11.04B | $100.99 - $198.87 | 0.00% |
| 14 | Halozyme TherapHALO | $95.77 | -0.22% | 1.30M | $10.92B | $61.23 - $134.00 | 0.00% |
| 15 | KymeraKYMR | $121.22 | -0.25% | 475.65K | $10.35B | $62.91 - $142.92 | 0.00% |
| 16 | Krystal BiotechKRYS | $315.09 | +5.60% | 231.79K | $9.34B | $202.99 - $382.54 | 0.00% |
| 17 | VaxcytePCVX | $58.57 | -1.45% | 868.81K | $9.27B | $42.40 - $90.75 | 0.00% |
| 18 | Twist BioscienceTWST | $116.27 | +3.86% | 1.78M | $7.29B | $24.41 - $219.71 | 0.00% |
| 19 | CG OncologyCGON | $79.97 | +1.28% | 1.50M | $7.14B | $37.01 - $93.95 | 0.00% |
| 20 | ImmunitybioIBRX | $6.71 | +7.35% | 14.64M | $7.14B | $1.95 - $12.43 | 0.00% |
| 21 | ImmunovantIMVT | $33.18 | -0.06% | 549.36K | $6.87B | $21.86 - $45.42 | 0.00% |
| 22 | Kodiak SciencesKOD | $97.76 | +1.03% | 501.57K | $6.14B | $18.14 - $112.79 | 0.00% |
| 23 | Scholar RockSRRK | $48.00 | +6.44% | 2.40M | $5.86B | $36.77 - $61.76 | 0.00% |
| 24 | Adaptive BiotechnologiesADPT | $28.44 | -0.14% | 1.93M | $4.60B | $12.00 - $32.21 | 0.00% |
| 25 | Crispr TherapeuticsCRSP | $40.19 | +0.02% | 2.76M | $3.90B | $39.80 - $63.45 | 0.00% |
| 26 | TarsusTARS | $75.95 | -2.83% | 341.96K | $3.75B | $53.89 - $91.53 | 0.00% |
| 27 | 雷利療法RLAY | $16.51 | +0.24% | 2.10M | $3.65B | $6.25 - $21.27 | 0.00% |
| 28 | Iovance BiotherapeuticsIOVA | $7.49 | -0.53% | 6.10M | $3.46B | $2.08 - $15.37 | 0.00% |
| 29 | ADMA Biologics IncADMA | $13.56 | -0.44% | 2.79M | $3.01B | $7.21 - $20.46 | 0.00% |
| 30 | Vericel Corp OrdVCEL | $58.63 | +1.28% | 698.19K | $2.99B | $28.95 - $59.75 | 0.00% |
| 31 | Denali TherapeuticsDNLI | $18.41 | +2.28% | 1.71M | $2.95B | $15.34 - $27.30 | 0.00% |
| 32 | BeamBEAM | $21.03 | +1.79% | 3.42M | $2.18B | $20.23 - $38.26 | 0.00% |
| 33 | Hemab TherapeuticsCOAG | $39.13 | -0.03% | 254.98K | $1.91B | $23.00 - $55.42 | 0.00% |
| 34 | BioCryst PharmaBCRX | $7.30 | -2.67% | 2.15M | $1.88B | $6.23 - $11.22 | 0.00% |
| 35 | ReplimuneREPL | $19.80 | +0.56% | 1.77M | $1.88B | $1.50 - $23.54 | 0.00% |
| 36 | Maze TherapeuticsMAZE | $31.23 | -4.99% | 613.41K | $1.88B | $21.95 - $53.65 | 0.00% |
| 37 | Recursion PharmaceuticalsRXRX | $2.83 | +3.68% | 37.59M | $1.76B | $2.50 - $5.24 | 0.00% |
| 38 | Vir BiotechVIR | $9.13 | -1.30% | 1.67M | $1.56B | $5.32 - $14.38 | 0.00% |
| 39 | AbsciABSI | $8.18 | +7.98% | 4.79M | $1.41B | $2.24 - $12.54 | 0.00% |
| 40 | NovavaxNVAX | $7.96 | -0.13% | 3.66M | $1.31B | $6.20 - $13.38 | 0.00% |
| 41 | Taysha GeneTSHA | $4.00 | -0.12% | 3.00M | $1.30B | $3.46 - $7.30 | 0.00% |
| 42 | Vor BiopharmaVOR | $17.85 | -1.93% | 662.07K | $1.10B | $6.50 - $26.00 | 0.00% |
| 43 | Inhibrx BiosciencesINBX | $69.06 | -7.10% | 252.07K | $1.02B | $57.30 - $155.29 | 0.00% |
| 44 | Odyssey TherapeuticsODTX | $18.97 | -2.17% | 316.45K | $920.02M | $15.10 - $29.05 | 0.00% |
| 45 | MeiraGTxMGTX | $8.30 | -1.89% | 422.60K | $811.65M | $6.62 - $15.35 | 0.00% |
| 46 | Monte Rosa TherapeuticsGLUE | $9.07 | +0.06% | 1.02M | $775.20M | $8.83 - $25.77 | 0.00% |
| 47 | Aura BiosciencesAURA | $7.14 | -0.28% | 569.72K | $743.19M | $4.73 - $9.54 | 0.00% |
| 48 | OmniAbOABI | $5.08 | +0.40% | 1.03M | $740.24M | $1.35 - $5.45 | 0.00% |
| 49 | Solid BiosciencesSLDB | $6.34 | +1.77% | 976.49K | $708.17M | $4.24 - $11.45 | 0.00% |
| 50 | Prime MedicinePRME | $3.83 | +0.66% | 3.70M | $695.58M | $2.67 - $5.91 | 0.00% |
| 現貨美股(RealStocks) | 代幣化美股(Tokenized Stocks) | 股票合約(Stock Futures) | |
|---|---|---|---|
| 是什麼 | 美股上市公司的真實股份(現貨美股) | 與美股/ETF 掛鉤的區塊鏈代幣 | 以 USDT 保證金進行的股價合約交易 |
| 所有權 | 是 —— 真實持股 | 否 —— 僅為合成敞口 | 否 —— 僅為衍生品敞口 |
| 股東權益 | 有(如分紅) | 無 | 無 |
| 交易時間 | 美股交易時段(盤前、正常、盤後、隔夜) | 24/7 全天候 | 支援交易對最高可達 24/7 全天候 |
| 持倉方式 | 買入並持有 | 買入並持有 | 支援多空雙向、槓桿交易 |
| 適合人群 | 追求長期持有和分紅收益的投資者 | 希望全天候獲得股票敞口、無需持有股票的交易者 | 希望通過槓桿進行投機或對沖的短線/活躍交易者 |
通過 MEXC 合作的持牌券商購買真實美股,並可按適用條件享有股息等股東權益。
覆蓋 7,000+ 隻美國上市股票及 ETF,涵蓋科技、金融、醫療、消費等多個行業。
支持 USDT 轉入及 USDT/USD 轉換,更便捷地為 RealStocks 帳戶提供資金。
以具有競爭力的交易成本參與真實美股交易,讓更多資金用於投資策略。
本頁面展示的美股價格、指數、排行榜、圖表及其他市場數據可能來自第三方數據提供商,並可能存在延遲或誤差。MEXC 提供的相關信息僅供參考和教育用途,不對其準確性或完整性作出保證。頁面內容不構成任何金融或投資建議,也不構成買賣任何證券的推薦。美股交易存在風險,歷史表現不代表未來結果,用戶應在作出投資決定前進行獨立研究。